and site of infection) and host factors (such as age, underlying disease, and resistance). Importantly, host genetic factors are now recognized to have a greater impact on the occurrence and progression of sepsis than environmental factors. [4] [5] [6] [7] The identification of genetic factors influencing the occurrence and progression of sepsis will allow the early detection of high-risk patients with sepsis, facilitating the prompt initiation of anti-infection therapy and treatment to support organ function and thereby improving prognosis in patients who develop this syndrome.
The mass production of inflammatory mediators is an important feature of sepsis. 3 Peroxisome proliferator-activated receptor-g (PPARγ) is a member of the nuclear receptor superfamily and a ligand-dependent nuclear transcription factor with multiple biological effects, including modulation of lipid and glucose metabolism and maintenance of homeostasis. 8 PPARγ is widely distributed in im- shown that administration of a PPARγ agonist can suppress the inflammatory responses associated with sepsis, 11 acute pancreatitis, 12 inflammatory bowel disease, 13 mastitis 14 and chronic airway inflammation, 15, 16 increasing the host's ability to kill and clear pathogenic microorganisms and improving prognosis. Therefore, PPARγ and its ligands have become a new therapeutic target for the treatment of sepsis and other inflammatory diseases. 17 Patients carrying a mutated PPARγ gene may be susceptible to excessive inflammatory responses, manifesting as a high susceptibility to sepsis and/or poor prognosis. However, investigations of the relation of PPARγ single-nucleotide polymorphisms (SNPs) with sepsis are rare and each concentrated on only one or a small number of SNPs. 18, 19 Hence, some SNPs of the PPARγ gene have yet to be investigated for their possible influence on the susceptibility to sepsis or the prognosis of this condition. Therefore, the aim of this study was to analyze the association between common SNPs in the PPARγ gene (a total of 13 SNPs) and the susceptibility to and clinical outcome of sepsis in a North China Han population. The identification of SNPs associated with the susceptibility to or prognosis of sepsis could potentially allow for the screening of patients at high risk for sepsis, permitting the instigation of early aggressive therapy and improving prognosis. 
| MATERIALS AND METHODS

| Subjects and design
| Collection of data
Socio-demographic data (age, sex, race, birthplace, height, and weight) and previous medical history, including history of tobacco and alcohol use, were collected from the sepsis and control groups using a questionnaire. The following baseline information was collected from patients in the sepsis group: laboratory and auxiliary examination re- 
| Genotyping
| RESULTS
| Characteristics of the study participants
A total of 310 patients with sepsis and 309 controls were enrolled.
During the genotyping process, some unreliable samples (seven from the sepsis group and six from the control group) were excluded due to low effective DNA concentrations or serious contamination;
therefore, the final analysis included 303 participants each in the sepsis and control groups. (Table 2) , although the sepsis group had more participants with COPD than the control group (6.93% vs 3.30%, P = .043).
| Clinical features in patients with sepsis
Additional clinical features of the patients with sepsis are shown in 
| Clinical outcomes in patients with sepsis
Septic shock occurred in 74/303 (24.42%) patients (Table 4) . Patients who developed septic shock were significantly older than those who did not (66.38 ± 18.21 vs 56.78 ± 18.38 years, P < .001) and had higher APACHE II score, MODS score, and mortality rate (all P < .001; Table 4 ). Other than hypertension incidence, there were no significant differences in other clinical characteristics between patients with septic shock and those without (Table 4) . Patients with severe organ dysfunction (65/303, 21.45%) had significantly higher APACHE II score, MODS score, and mortality rate than those with mild organ dysfunction (all P < .001); other clinical features were similar (Table 4) .
Mortality rate was 79/303 (26.07%). Patients who died were significantly older and had higher APACHE II and MODS scores than those who survived (P < .001; Table 4 ).
| Association of PPARγ gene polymorphisms with susceptibility to and clinical outcome of sepsis
The frequency distributions of all SNPs in the control group were in
Hardy-Weinberg equilibrium. The results of the logistic regression analysis, after adjusting for age, sex, BMI, tobacco use, alcohol use, and underlying diseases, are presented in Table 5 . For rs2972164, 
T A B L E 3 Clinical characteristics of the septic patients
Clinical characteristic Value
Number of patients with sepsis 303
Site of infection, n (%) Table 6 ). No differences in SNP frequency distributions were observed between patients with septic shock or death (data not shown).
In this study, we inferred 3 haplotype blocks from the PPARγ gene ( Figure 1 ). 
| DISCUSSION
This study analyzed the association between 13 common SNPs from the PPARγ gene and the occurrence and progression of sepsis in a North China Han population. The main finding was that there were 3 SNPs related to the occurrence or progression of sepsis: (i) rs1801282 (C→G) was associated with a reduced risk of sepsis; (ii) rs2972164 (C→T) was associated with an increased risk of sepsis; and (iii) rs4135275 (G→A) was associated with an increase in the severity of organ dysfunction following the occurrence of sepsis. No SNP was found to correlate with septic shock or death. In addition, the haplotype TAT (rs2972164, rs4684846, and rs17036188), containing the rs2972164 T allele, was related to increased risk of sepsis, whereas haplotype CTGA, containing the rs1801282 G allele, was related to decreased risk of sepsis (P = .09, not shown in the text), which was consistent with the individual SNP analyses. To the best of our knowledge, this is the first study to investigate the influences of such an extensive range of PPARγ gene SNPs (13 in total). These results suggest that certain PPARγ gene mutations could be correlated with the occurrence and progression of sepsis.
T A B L E 4
Characteristics of the patients with sepsis stratified by septic shock occurrence, severity of organ dysfunction, and mortality The PPARγ gene is located on chromosome 3p25 and contains 9
exons. The rs1801282 polymorphism, located in exon 2, is the most extensively studied SNP in the PPARγ gene and results in a CCA→GCA nonsynonymous mutation encoding a proline→alanine substitution at amino acid residue 12 (Pro12Ala). The incidence of this polymorphism varies between different populations (fluctuating between 2% and 25%)
and is significantly lower in the Asian population than the Caucasian population. 26 In this study, the frequency of the G allele was 7.92% in the control group, similar to that reported by Wang et al 27 (7.2%), Shi et al 28 (7.9%), and Pei et al 29 (7.55% ). Due to the low frequency and sample size, occurrence of the homozygous mutation (GG) of this SNP was zero in the control group and 1 in the sepsis group, respectively.
A notable finding of our study was that rs1801282 (C→G) ap- Guangdong Medical College and found that rs1801282 (G) was not associated with susceptibility to sepsis, in contrast to our findings.
However, patients carrying the G allele had lower disease severity and a better prognosis than those with the C allele. 18 The reasons underlying the apparent inconsistency between our study and that of Ma et al 18 remain unknown, but may include a small sample size in both studies or differences in the ethnicities of the participants, the T A B L E 6 Association between polymorphisms of the PPARγ gene and organ dysfunction of sepsis pathogenic microbes involved or environmental factors. Nonetheless, both our study and that of Ma et al 18 implicate rs1801282 (C→G) as having a protective role against sepsis, either in terms of the risk of acquiring it or in terms of its prognosis.
Several previous studies have examined the correlation between rs1801282 and T2DM, with most suggesting that the rs1801282 variant was a metabolic protective factor. A recent meta-analysis revealed that this mutation was related to low risk of T2DM, 30 and Pei et al others ,have suggested no effect. 33 A recent meta-analysis 34 In this study, the other 2 SNPs that associated with sepsis were both located in the intron: rs2972164 (C→T) was associated with an increased risk of sepsis, while rs4135275 (G→A) was associated with an increase in the severity of organ dysfunction following the and rs1175543 selected in our study. However, we did not find that rs11128601 or rs1175543 were associated with the risk of sepsis or its prognosis. As discussed above, possible reasons for this discrepancy include small sample size or differences in ethnicities, pathogenic microbes involved, or environmental factors.
The present study enrolled only subjects native to the North China area, minimizing the impact of population stratification on the results.
Furthermore, since sepsis is a multifactorial disease influenced by many genes and mutations, we decided not to concentrate on just one or a small number of SNPs located at the coding or promoter region, as previous studies have done, but instead to select a wider range of SNPs (13 in total) through a combination of methods, so as to maximally represent the common genetic information from the PPAR gene.
In addition to the individual SNP analyses, haplotype block and haplotype were also inferred in the current study. Since a haplotype usually has several SNPs and thus contains more genetic information, the statistical efficiency of haplotype analysis is higher. It is noteworthy that the results from the individual SNP analyses are consistent with those from the haplotype analysis, further validating the reliability of our data.
This study has some limitations. First, since all the patients with sepsis were enrolled from a hospital while the controls were enrolled from a population attending for physical examination during the same period, there is selection bias in the study.
However, to maintain a minimum level of potential confounding factors, the cases and controls were matched in every aspect possible, including age, sex, tobacco and alcohol use, hypertension, CHD, hyperlipidemia, and T2DM. Second, due to inadequate statistical power resulting from a small sample size, the effects of some SNPs with a low penetrance could not be evaluated. Third, for similar reasons, certain associations may not have been revealed in the subgroup analysis. Finally, SNPs were selected from the databases of dbSNP and HapMap. Since these 2 databases are still improving with the constant discovery of emerging SNPs, our selection cannot represent all the variants of the PPARγ gene.
Thus, it remains possible that other SNPs may also associate with sepsis. Our next step is to test the current results and conduct functional analyses in a larger and wider population consisting of various ethnicities.
In conclusion, this study found that 3 SNPs were associated with the occurrence or progression of sepsis: (i) rs1801282 (C→G) was associated with a reduced risk of sepsis; (ii) rs2972164 (C→T) was associated with an increased risk of sepsis; and (iii) rs4135275 (G→A) was associated with more severe organ dysfunction following the development of sepsis. No SNP was found to associate with septic shock or death. These results indicate that PPARγ gene mutations are relative to the development and progression of sepsis.
